Back to ROYAL BANK OF CANADA ROYAL BANK OF CANADA

BCTXBCTX
4 quarters

Position history for ROYAL BANK OF CANADAROYAL BANK OF CANADA's holdings in BRIACELL THERAPEUTICS CORP

Yes. Royal Bank of Canada holds 289 shares of BCTX (Briacell Therapeutics), worth $1,000, as of its Q2 2026 13F filing. It increased the position by 189 shares (+189.0%) from Q1 2026. Royal Bank of Canada has held BCTX since Q3 2025, across 4 quarterly 13F filings.

Current Value

$1,000

Current Shares

289

Total Value Change

$0

Total Shares Change

+189

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
289
+189.0%
$1,0000.0%$3.24
12
2026-Q1
Unchanged
100
0.0%
$00.0%$4.19
0
2025-Q4
Unchanged
100
0.0%
$1,0000.0%$7.11
0
2025-Q3
New
100
-
$1,0000.0%$11.00
17

Other major holders of BCTX: UBS Group AG, CITADEL ADVISORS LLC, HRT FINANCIAL LP, JANE STREET GROUP, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used